α-(aminomethyl)-2-thiophenmethanol | 62019-66-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: α-(aminomethyl)-2-thiophenmethanol
• 英文别名: 2-ammino-1-(2-tienil)etanolo；2-amino-1-(thien-2-yl)-ethanol；2-amino-1-thienylethanol；2-amino-1-[2]thienyl-ethanol；2-Amino-1-[2]thienyl-aethanol；2-amino-1-(2-thienyl)-ethanol；2-Amino-1-thiophen-2-yl-ethanol；2-amino-1-thiophen-2-ylethanol
• CAS: 62019-66-3
• 化学式: C₆H₉NOS
• mdl: MFCD04038402
• 分子量: 143.21
• InChiKey: LOULKRKJFMPTJQ-UHFFFAOYSA-N

物化性质

• 熔点：
  81-82 °C(Solv: benzene (71-43-2))
• 沸点：
  298.7±25.0 °C(Predicted)
• 密度：
  1.259±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  74.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  α-(aminomethyl)-2-thiophenmethanol 在 盐酸 、 sodium hydroxide 、 sodium tetrahydroborate 、 lithium aluminium tetrahydride 、 sodium 、 potassium carbonate 、 sodium iodide 作用下， 反应 79.0h， 生成
  参考文献：
  名称：

  Carissimi; Picciòla; Ravenna, Farmaco, Edizione Scientifica, 1980, vol. 35, # 10, p. 812 - 825

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氧代-2-(噻吩-2-基)乙-1-氯化铵 在 硼酸三钠 、 水 作用下， 生成 α-(aminomethyl)-2-thiophenmethanol
  参考文献：
  名称：

  A THIOPHENE ISOSTER OF CHLORAMPHENICOL IN THE ERYTHRO SERIES¹

  摘要：

  DOI：

  10.1021/jo01129a005

文献信息

• Hypocholesterolemic agents
  申请人：Pfizer Inc.

  公开号：US05939398A1

  公开（公告）日：1999-08-17

  This invention relates to certain steroidal glycosides useful as hypocholesterolemic agents and antiatherosclerosis agents and certain protected intermediates useful in the preparation of said steroidal glycosides.

  本发明涉及某些类固醇甙类化合物，可用作降胆固醇药物和抗动脉粥样硬化药物，以及在制备上述类固醇甙类化合物过程中有用的某些保护中间体。
• A convenient one-pot synthesis and bioactivity of <i>N</i> -dichloroacetyl-5-aryl-1,3-oxazolidines
  作者：Fei Ye、Cheng-Guo Liu、Xin-Ming Wang、Ying Fu、Shuang Gao

  DOI：10.1515/hc-2013-0042

  日期：2013.6.1

  Abstract New N-dichloroacetyl-5-aryl-1,3-oxazolidines 4 were synthesized by cycloaddition reaction of an aryl substituted hydroxyalkylamine 1 with aldehyde or ketone 2, followed by acylation, without isolation of the intermediate product 3. The structures of compounds 4 were determined by spectral and elemental analyses. The structure of 4b was determined by an X-ray crystallographic analysis. The

  摘要 通过芳基取代的羟烷基胺 1 与醛或酮 2 的环加成反应，然后酰化，无需分离中间产物 3，合成了新的 N-二氯乙酰基-5-芳基-1,3-恶唑烷 4。 化合物 4 的结构通过光谱和元素分析确定。4b 的结构是通过 X 射线晶体学分析确定的。生物测定结果表明，这些化合物可以减轻氯磺隆对玉米的损伤。
• Arylalkylamine derivatives
  申请人：Kyowa Hakko Kogyo Co., Ltd.

  公开号：US05128369A1

  公开（公告）日：1992-07-07

  Disclosed is a novel arylalkylamine derivative represented by the formula (I) ##STR1## wherein X represents --O--, --CH.sub.2 -- or --NR.sup.3 -- in which R.sup.3 represents hydrogen or lower alkyl; Y represents --NH-- or ##STR2## Z represents ##STR3## in which R.sup.4 represents hydrogen or lower alkyl or ##STR4## Q represents an optionally substituted aryl or optionally substituted aromatic heterocyclic group; each of R.sup.1 and R.sup.2 independently represents hydrogen or lower alkyl; each of m and n independently represents an integer of 0 or 1; and a pharmaceutically acceptable salt thereof. The compound (I) and a pharmaceutically acceptable salt thereof show bronchodilatory and antiallergic activities, and are useful for treating respiratory disorders such as bronchial asthma.

  本发明涉及一种新型芳基烷基胺衍生物，其化学式表示为(I)##STR1##其中，X代表--O--，--CH.sub.2--或--NR.sup.3--，其中R.sup.3代表氢或低碳基；Y代表--NH--或##STR2##Z代表##STR3##其中R.sup.4代表氢或低碳基或##STR4##Q代表可选取代的芳基或可选取代的芳香族杂环基；每个R.sup.1和R.sup.2独立地代表氢或低碳基；每个m和n独立地代表0或1的整数；以及其药学上可接受的盐。化合物(I)及其药学上可接受的盐具有支气管扩张和抗过敏活性，可用于治疗支气管哮喘等呼吸系统疾病。
• N-Alkylated aminoalcohols and their pharmaceutical compositions useful
  申请人：Ciba-Geigy Corporation

  公开号：US04460580A1

  公开（公告）日：1984-07-17

  The invention relates to novel N-alkylated aminoalcohols of the formula ##STR1## in which Ar is a radical of aromatic character which is unsubstituted or substituted by hydroxyl, n has the values nought or 1 and Alk is an alkylene radical having 2 to 5 carbon atoms and the nitrogen atom and the oxygen atom or, if n is nought, the salicylamide radical are separated from one another by at least two carbon atoms in the straight-chain, and their salts. The main action of the novel compounds consists in a stimulation of cardiac .beta.-receptors; the compounds also effect a blockage of adrenergic .alpha.-receptors and a lowering in the blood pressure. They can therefore be used as .beta.-stimulators, especially as agents having a positively inotropic action for the treatment of cardiac insufficiency. Compounds of the formula I in which Ar is phenyl, unsubstituted or substituted by 1 or 2 hydroxyl groups, Alk is an alkylene radical having 2 to 4 carbon atoms, n has the value 1, and the nitrogen atom and the oxygen atom are separated from one another by at least 2 carbon atoms in the straight-chain, or salts thereof, exhibit effects on the central nervous system, which are reflected for example in the suppression of the symptoms of impaired sympathetic functions and in the suppression of lack of initiative. Such compounds of the formula I therefore can be used for the treatment of reactive or endogenic states of depression of varying degrees of severity, and also for the treatment of neurotic or other psychic disturbances involving loss of initiative and depressive disorders. Such compounds can also be used for the short-term treatment of post-partum or postoperative depression, or of depression of different origin. Such compounds of the formula I can be used on their own or in combination with other antidepressants.

  本发明涉及新型N-烷基氨基醇，其化学式为##STR1##其中，Ar是具有芳香性质的基团，可以是未取代或取代的羟基；n的值为零或1；Alk是具有2至5个碳原子的烷基基团，且直链中氮原子和氧原子或者如果n为零，则水杨酰胺基团之间至少相隔两个碳原子；以及它们的盐。新型化合物的主要作用是刺激心脏β-受体；这些化合物还能够阻断肾上腺素α-受体和降低血压。因此，它们可以用作β-刺激剂，特别是具有正性肌力作用的药物，用于治疗心力衰竭。化合物I的Ar为苯基，在直链中氮原子和氧原子之间至少相隔2个碳原子，Alk为具有2至4个碳原子的烷基基团，n的值为1，或其盐，表现出对中枢神经系统的作用，例如抑制交感功能障碍的症状和抑制缺乏主动性的症状。因此，化合物I可用于治疗不同程度的反应性或内源性抑郁状态，以及神经症或其他精神障碍，包括缺乏主动性和抑郁症。这些化合物还可用于短期治疗产后或手术后抑郁症，或不同起源的抑郁症。这些化合物可以单独使用或与其他抗抑郁药物联合使用。
• Heteroaryl-ethanolamine derivatives as antiviral agents
  申请人：Schnute E. Mark

  公开号：US20050049245A1

  公开（公告）日：2005-03-03

  The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.

  本发明提供了一种如下所述的化合物，它们可用作抗病毒剂，特别是用作针对疱疹家族病毒的药物。